Cargando…
Comparative effectiveness and cost-effectiveness of target- versus benefit-based treatment of type 2 diabetes in low- and middle-income countries
BACKGROUND: How to optimally prescribe blood pressure, lipid and glucose-lowering treatments to adults with type 2 diabetes in low- and middle-income countries (LMICs) remains unclear. METHODS: We developed a microsimulation model to compare: (i) a “treat to target” (TTT) strategy, aiming to achieve...
Autores principales: | Basu, Sanjay, Shankar, Vishnu, Yudkin, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315061/ https://www.ncbi.nlm.nih.gov/pubmed/27717768 http://dx.doi.org/10.1016/S2213-8587(16)30270-4 |
Ejemplares similares
-
Cost-effectiveness versus treatment effectiveness: A radiation oncologist's dilemma in low-income and middle-income countries (LMIC)
por: Iyer, Priya
Publicado: (2022) -
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023) -
Conducting Benefit-Cost Analysis in Low- and Middle-Income Countries: Introduction to the Special Issue
por: Robinson, Lisa A., et al.
Publicado: (2019) -
The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
por: Kostova, Deliana, et al.
Publicado: (2020) -
Comparative Performance of Private and Public Healthcare Systems in Low- and Middle-Income Countries: A Systematic Review
por: Basu, Sanjay, et al.
Publicado: (2012)